Illumina
NASDAQ:ILMN
$54.05
$0.16
(0.30%)
Quote as of 4:00 PM EST on 02/13/12
|
$54.05
|
|
| Today's Open | $53.95 |
|---|---|
| Previous Close | $53.89 |
| Daily Range | $53.60 - $54.20 |
| 52-Week Range | $25.57 - $79.40 |
| Market Cap | $6.56B |
| P/E Ratio | 69.09 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 1,264,065 |
| Average Daily Volume | 4,537,277 |
| Current FY EPS | $1.48 |
ILMN Information
| Description |
|---|
| The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function. |
| Sector |
| Healthcare |
| Industry |
| Life Sciences Tools and Services |
News & Commentary
Does This Hostile Takeover Make Sense?
Illuminating the Way Forward for Genomics
Affymetrix Misses as Sales Dip - Analyst Blog
Zacks Bull and Bear of the Day Highlights: Amgen, Montpelier Re Holdings, Cisco Systems, Illumina an
Illumina Beats, Spurns Roche Offer - Analyst Blog
Illumina Beats on EPS but GAAP Results Lag
US STOCK FUTURES: HOT STOCKS TO WATCH
Life Technologies' Sequence of Success
Life Technologies Beats, Profit Up - Analyst Blog
Roche Hostile Bid for Illumina is Just Getting Started
